A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC
Clinical trial NCT07385001 · RECRUITING
Trial details
- NCT number
- NCT07385001
- Sponsor
- Tang-Du Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-28
- Primary completion
- 2027-01-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.